We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current INDP market cap is 9.56M. The company's latest EPS is USD -1.5125 and P/E is -6.37.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.25M | -4.18M | -3.94M | -4.11M | -3.14M |
| Net Income | -3.92M | -4M | -3.81M | -4.02M | -3.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.5M | 0 | 0 | 0 | 0 |
| Operating Income | -43.01M | -13.83M | -7.73M | -14.91M | -16.38M |
| Net Income | -47.6M | -14.13M | -7.71M | -14.32M | -15.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.79M | 14.92M | 10.95M | 8.12M | 8.24M |
| Total Liabilities | 2.46M | 2.85M | 1.59M | 1.96M | 2.24M |
| Total Equity | 15.33M | 12.08M | 9.36M | 6.17M | 6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.28M | 20.9M | 40.58M | 28.06M | 14.92M |
| Total Liabilities | 9.75M | 6.36M | 4.68M | 3.43M | 2.85M |
| Total Equity | 11.54M | 14.53M | 35.9M | 24.63M | 12.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.8M | -13.41M | -3.94M | -6.41M | -8.93M |
| Investing | 17.14M | 17.14M | N/A | N/A | N/A |
| Financing | N/A | N/A | 316k | 354k | 2.95M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.05M | -11.51M | -11.29M | -13.08M | -13.41M |
| Investing | -3.21M | 750k | 448k | -16.43M | 17.14M |
| Financing | 2.37M | 15.98M | 48.34M | N/A | N/A |
| Market Cap | 9.56M |
| Price to Earnings Ratio | -6.37 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.35 |
| Price to Book Ratio | 8.13 |
| Dividend Yield | - |
| Shares Outstanding | 10.2M |
| Average Volume (1 week) | 21.47k |
| Average Volume (1 Month) | 24.5k |
| 52 Week Change | -51.65% |
| 52 Week High | 3.10 |
| 52 Week Low | 0.84 |
| Spread (Intraday) | 0.23 (20.71%) |
| Company Name | Indaptus Therapeutics Inc |
| Address |
1007 north orange street wilmington, delaware 19801 |
| Website | https:// |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
